Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aurobindo Pharma Ltd.

www.aurobindo.com

Latest From Aurobindo Pharma Ltd.

Private Label Nexium OTC Buoys Perrigo As Pricing Trims Rx Revenues

Perrigo's third-quarter launch of private label Nexium24HR was primary contributor of $13m in new product sales in North America.

Consumer Consumer

Cipla Primes For US Momentum But Seretide Generic Is Slow In UK

Cipla reported a strong second quarter, with management upbeat about building momentum in the US business with a “good mix” of differentiated launches. The ramp-up of the firm’s Seretide generic in the UK, though, appears slow.

Generic Drugs Strategy

Decision Against Attorney Fees In Mucinex Patent Claim Could Resonate

US federal court judge says Mucinex marketer Reckitt Benckiser is not responsible for OTC private label competitor Aurobindo’s attorney fees because its patent infringement complaint was not “exceptional” and its argument had merit. The decision could bolster drug firms' confidence in defending their patents.

Consumer Legal Issues

Perrigo's Next Private Label First Lands With Second Thoughts On Outlook

The launch of a private label version 24HR OTC heartburn treatment comes with Perrigo in need of another high-selling product to boost revenues in its core business, OTC private label. But analysts call for Perrigo to do more to grow in new markets.

Consumer Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Aurobindo Pharma Ltd.
  • Senior Management
  • N Govindarajan, Mng. Dir.
  • Contact Info
  • Aurobindo Pharma Ltd.
    Phone: (91) 40 6672 5000
    WaterMark Bldg., Level 1
    Plot #11,Surv#9
    Hyderabad, 500 084
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register